Nevada gets $1.5M in diabetes drug settlement
LAS VEGAS (AP) — Nevada is getting $1.5 million to settle claims that a pharmaceutical company deceptively promoted the diabetes drug Avandia.
Nevada Attorney General Catherine Cortez Masto says Thursday that Nevada's portion is part of a $90 million settlement between GlaxoSmithKline and attorneys general from 38 different states.
The attorneys general claim the company misrepresented Avandia's cardiovascular risks and safety profile. The agreement requires the company to reform its marketing practices, and to publicize information about any company-sponsored clinical trials on its diabetes drugs.
A GlaxoSmithKline spokeswoman says the settlement doesn't admit any wrongdoing. She says the company firmly believes it acted responsibly in testing, marketing, and monitoring the safety of Avandia.
News Photo Galleriesview all
- 11499Oklahoma devastated by second round of twisters
- 10241At least 51 die in Oklahoma tornado, official says
- 8698Read live updates from the May 20 Moore tornado
- 7434How to help tornado victims
- 4914Several kids pulled out of Oklahoma school rubble alive
- 2111Oklahoma twister tracked path of 1999 tornado
- 1490Oklahoma City tornado so large, may not be recognized, officials say